Mitomycin C Plasma Levels after Intravesical Instillation with and without Hyaluronidase
- 1 April 1986
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 135 (4) , 845-846
- https://doi.org/10.1016/s0022-5347(17)45873-3
Abstract
In 20 patients undergoing transurethral resection for bladder tumor or multiple transurethral biopsies for monitoring after transurethral resection, mitomycin C, 20 mg., was instilled into the bladder immediately after the procedure. Mitomycin C was associated with hyaluronidase, 20,000 U, in 10 patients. Serum levels of mitomycin were determined by column chromatography 30 and 60 minutes after instillation. Hyaluronidase was not found to make any difference in mitomycin absorption. Potential expansions of the therapeutic modalities for preventing recurrent bladder tumor by hyaluronidase are discussed.This publication has 6 references indexed in Scilit:
- Intravesical Therapy of Noninvasive Bladder Tumors (Stage Ta) with Doxorubicin and UrokinaseJournal of Urology, 1983
- Randomized clinical trial on chemoprophylaxis of recurrence in cases of superficial bladder cancerCancer Chemotherapy and Pharmacology, 1983
- Serum- und Gewebe-Mitomycin-C-Spiegel nach intravesikaler InstillationUrologia Internationalis, 1983
- Mitomycin Instillation to Prevent Recurrence of Superficial Bladder CarcinomaEuropean Urology, 1983
- The Prophylactic Use of Thio-Tepa and Urokinase in Transitional Cell Carcinoma of the Bladder: A Preliminary ReportJournal of Urology, 1975